The effect of Ellagic acid supplementation in patients with type 2 diabetes
Phase 3
Recruiting
- Conditions
- type 2 diabetes.Type 2 diabetes mellitus
- Registration Number
- IRCT20121028011288N18
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 46
Inclusion Criteria
patients with type 2 diabetes
Using blood sugar lowering medicine
Age range of 30-60 years
BMI in the range of 25-35
1 to 15 years duration of type 2 diabetes
Tendecy of corporation
Exclusion Criteria
Use of corticosteroids, steroidal and non-steroidal anti-inflammatory drugs
Prescribing insulin
Suffering from chronic diseases such as heart failure, kidney, liver and thyroid disorders
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method